New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors

Publisher： Karger

E-ISSN： 1662-0631|9|1|106-112

ISSN： 1662-0631

Source： Case Reports in Gastroenterology, Vol.9, Iss.1, 2015-04, pp. : 106-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease

By  

Digestion, Vol. 88, Iss. 1, 2013-06 ,pp. : 17-19

Karger

Access to resources Recommend Favorite

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

By  

Case Reports in Gastroenterology, Vol. 8, Iss. 1, 2014-01 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor Nonresponders in Crohn’s Disease: Therapeutic Strategies

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 351-357

Karger

Access to resources Recommend Favorite

Tumor Necrosis Factor-Alpha in Ileal Mast Cells in Patients with Crohn’s Disease

By  

Digestion, Vol. 61, Iss. 1, 2000-02 ,pp. : 68-76

Karger

Access to resources Recommend Favorite

An Open-Label Pilot Study of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Endoscopic Postoperative Recurrence in Crohn’s Disease

By  

Digestion, Vol. 68, Iss. 2-3, 2004-01 ,pp. : 63-70

Karger

Access to resources Recommend Favorite